The FDA approved the phase 2 Explore-OSA trial set to assess the highly selective aldosterone synthase inhibitor, ...
Individuals with negative colonoscopy screening results had lower long-term risk for colorectal cancer and related mortality, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback